Guest guest Posted September 17, 2010 Report Share Posted September 17, 2010 Just checked out the clinical trials page for cal-101 on the Calistoga Pharma website, it's moving into phase 2. However, it really, really sucks that the only people who are accepted are those who are relapsed/refractory to " standard " cll tx.. Why can't they include a cohort of tx.-naive patients? Perhaps it would work even better in those whose immune systems are still functional, albeit imperfect. Ellen Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.